Identification of cardiovascular autonomic neuropathy in diabetic patients is crucial for tailoring exercise regimens, monitoring for ischemia, and aggressively treating cardiovascular risk factors.
No takes yet. Share an insight, caveat, or question.
Supports CAN screening for exercise and ischemia guidance in diabetes; leaves open optimal therapies pending prospective trials.
Maser et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: